Ardelyx Correlations
| ARDX Stock | USD 6.79 0.08 1.16% |
The current 90-days correlation between Ardelyx and Zymeworks Common Stock is 0.14 (i.e., Average diversification). The correlation of Ardelyx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Ardelyx Correlation With Market
Poor diversification
The correlation between Ardelyx and DJI is 0.72 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Ardelyx Stock
| 0.8 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.84 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.66 | CMB | Cambium Bio | PairCorr |
| 0.68 | VALN | Valneva SE ADR | PairCorr |
| 0.66 | DNLI | Denali Therapeutics | PairCorr |
| 0.73 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.87 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.88 | DRTS | Alpha Tau Medical | PairCorr |
| 0.83 | 0P6S | Bayer AG NA | PairCorr |
| 0.82 | DVAX | Dynavax Technologies Earnings Call This Week | PairCorr |
Moving against Ardelyx Stock
| 0.61 | OSE | OSE Pharma SA | PairCorr |
| 0.54 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.53 | VCYT | Veracyte | PairCorr |
| 0.47 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.44 | DRMA | Dermata Therapeutics | PairCorr |
| 0.35 | VCEL | Vericel Corp Ord | PairCorr |
| 0.82 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.79 | XE9 | Xencor Inc | PairCorr |
| 0.74 | VSTM | Verastem | PairCorr |
| 0.69 | VKTX | Viking Therapeutics | PairCorr |
| 0.69 | VRAX | Virax Biolabs Group | PairCorr |
| 0.67 | BIM | Biomerieux SA | PairCorr |
| 0.66 | DTIL | Precision BioSciences | PairCorr |
| 0.63 | VTGN | VistaGen Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ardelyx Stock performing well and Ardelyx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ardelyx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZYME | 2.65 | 0.45 | 0.12 | (1.13) | 2.60 | 4.76 | 36.09 | |||
| MAZE | 2.78 | 0.65 | 0.20 | 1.65 | 2.68 | 6.77 | 20.03 | |||
| BCRX | 1.93 | (0.11) | 0.00 | (0.11) | 0.00 | 4.43 | 16.75 | |||
| TRVI | 2.86 | (0.16) | 0.00 | (0.11) | 0.00 | 6.73 | 25.67 | |||
| SYRE | 2.72 | 0.75 | 0.26 | 0.67 | 2.45 | 7.15 | 20.03 | |||
| NTLA | 3.71 | 0.25 | 0.08 | 0.15 | 4.21 | 10.12 | 23.60 | |||
| PHVS | 3.32 | 0.23 | 0.07 | 0.21 | 3.45 | 6.58 | 27.81 | |||
| WVE | 5.99 | 1.96 | 0.39 | (0.98) | 3.74 | 6.72 | 164.47 | |||
| STOK | 3.16 | 0.55 | 0.16 | 0.59 | 3.05 | 8.20 | 22.69 | |||
| UPB | 4.71 | (1.09) | 0.00 | (1.47) | 0.00 | 7.84 | 57.85 |
Ardelyx Corporate Management
| Elizabeth Esq | Chief Secretary | Profile | |
| James Brady | Chief Officer | Profile | |
| Susan Rodriguez | Chief Officer | Profile | |
| Joseph Reilly | Senior Officer | Profile | |
| Sue Hohenleitner | Chief Officer | Profile |